Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical data

scientific article published on 26 March 2020

Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical data is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/NEUONC/NOAA072
P932PMC publication ID7566367
P698PubMed publication ID32215549

P50authorPatrick Y WenQ105531697
P2093author name stringLi Yang
Ke Jin
Hao Zhou
Jing Wu
Jian Peng
Bo Xiao
Jerrold Boxerman
Qin Shen
Harrison X Bai
Ken Chang
Raymond Y Huang
Panpan Wang
Xiaoping Gao
Xiaowei Zeng
Sohil H Patel
Yanhe Xiao
Chongyu Hu
Oliver Tang
P2860cites workMolecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasQ34167499
Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.Q34739729
Leptomeningeal metastases: a RANO proposal for response criteria.Q36236770
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaQ36929844
Divergent clonal selection dominates medulloblastoma at recurrenceQ37073617
Pediatric brain tumors: current treatment strategies and future therapeutic approachesQ37533670
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysisQ37636027
Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumoursQ37769645
Response Assessment in Medulloblastoma and Leptomeningeal Seeding Tumors: Recommendations from the Response Assessment in Pediatric Neuro-Oncology CommitteeQ39267054
Declines in Cancer Death Rates Among Children and Adolescents in the United States, 1999-2014.Q39371269
The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with BevacizumabQ40405075
Latency of intracranial germ cell tumors and diagnosis delayQ42440685
High response rate to cisplatin/etoposide regimen in childhood low-grade gliomaQ44178093
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working groupQ48271471
Distinguishing between germinomas and pineal cell tumors on MR imagingQ48773590
A Hematogenous Route for Medulloblastoma Leptomeningeal MetastasesQ57261173
Challenges with defining response to antitumor agents in pediatric neuro-oncology: A report from the response assessment in pediatric neuro-oncology (RAPNO) working groupQ58001390
Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade gQ81061350
MedulloblastomaQ86064194
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016Q91054612
P4510describes a project that usesmagnetic resonance imagingQ161238
P921main subjectmedulloblastomaQ1333608
P577publication date2020-03-26
P1433published inNeuro-OncologyQ15724471
P1476titleEvaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical data

Search more.